Clinical Trials

Sterling Pharma Solutions and Kivu Bioscience Enter Manufacturing Pact

Sterling Pharma Solutions to produce an antibody-drug conjugate (ADC) candidate for Kivu Bioscience.

Catalent Completes Shanghai Plant Expansion

US-headquartered CDMO giant Catalent has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.

US Merck Halts Trial Enrollment After Deaths

Bioelectronic Medicines: A New Type of Personalization

FDA Approves NuvOx IND Brain Tumor Trial

Novartis’ Zykadia Wins FDA Priority Review

Acquisition to Complement UPS Healthcare Logistics Solutions

France to Tighten Rules on Clinical Trials

AstraZeneca Initiates Broad Genomics Project

Restrictions on Drug Trials Proposed After French Death

Pharma Majors Join Parkinson’s Initiative

Catalent to Add GMP Space at Singapore

Volunteer Dies in French Drug Trial

Lilly Discontinues Potential Blockbuster

Chinese Market for Colorectal Cancer Drugs Exploding

CPhI Worldwide Announces International Advisory Board

Russian Scientists Said Working on Three Ebola Vaccines

Discovering the Future of Pharma

Merck Serono and Sutro to Collaborate on ADCs

Lucentis and Avastin Said to Have Similar Side Effects

EU Looks to Speed Drug Access With Staggered Approval

European Parliament Approves Clinical Trials Legislation

PCRAMS is a Booming Business

Outsourcing Biopharmaceutical Manufacturing

Russia’s and Eastern Europe’s Booming Pharma Industry

Ending Drug Trial Secrecy Is a Boon for R&D, Says EU Agency

Sanofi’s Chris Viehbacher: EU’s Drug Data Stance Threatens Investment

U.S. Launch of Novo's New Insulin Faces Long Delay

Court Stops EU Regulator Releasing Drug Company Data

New Gene Therapy Trials Aim to Mend Broken Hearts

Roche to Release All Tamiflu Drug Data

Switzerland's Roche Pledges to Open Up Access to Drug Data

FDA Halts Trials of Amgen Drug in Children, Cites Death

Merck to Pay $688 Million to Settle Enhance Lawsuits

Slow Approvals Put India's Drug Trials Industry at Risk